Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign intracranial hypertension.

C M Cody1

  • 1University of California, Davis.

American Family Physician
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Benign intracranial hypertension (BIH) causes vision loss in young people. Diagnosis involves clinical assessment and excluding brain masses, with treatments focused on reducing intracranial pressure.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Further immunization studies with mammary tumor virus.

Cancer research·1976
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Area of Science:

  • Neurology
  • Ophthalmology

Background:

  • Benign intracranial hypertension (BIH) is a significant cause of progressive visual loss.
  • It particularly affects children and young adults, necessitating timely diagnosis and management.

Purpose of the Study:

  • To summarize the diagnostic and therapeutic approaches for benign intracranial hypertension.
  • To highlight the typical clinical course and prognosis of the condition.

Main Methods:

  • Diagnosis relies on clinical presentation, exclusion of intracranial masses via radiography, and cerebrospinal fluid pressure measurement.
  • Treatment strategies focus on reducing intracranial pressure, addressing underlying causes, and managing symptoms.

Main Results:

  • Idiopathic BIH is managed by reducing intracranial pressure using medications like carbonic anhydrase inhibitors, diuretics, and steroids.
  • Surgical intervention is reserved for cases with rapid vision loss or treatment-resistant conditions.

Conclusions:

  • Benign intracranial hypertension is generally a self-limited condition, with most cases resolving within 12 months.
  • Effective management involves a combination of medical and, in select cases, surgical interventions to preserve vision.